WHO India’s 22 October 2026 release outlines a 2030 mercury-free health-care goal. A detailed CHC/PHC guide to device replacement, accuracy, spill safety and mercury-waste management.
WHO schedules a 28 October 2026 EPI-WIN webinar on influenza and COVID-19 prevention. A practical respiratory-season prevention and CHC readiness checklist, without claiming the webinar has already concluded.
CDSCO’s 26 October 2026 notice concerns misleading or false claims for FatX solution marketed under a cosmetic registration. What clinicians and consumers should verify before aesthetic procedures.
CDSCO’s 26 October 2026 listing highlights a WHO alert concerning falsified DEFITELIO (defibrotide) batch 24GC01A identified in India. Practical verification, quarantine and reporting steps for hospital pharmacies.
WHO’s 5 October 2026 report covers 28 Asia-Pacific countries, underfunded AMR plans and Access antibiotic use. Six practical stewardship actions for CHCs and hospitals.
WHO’s 23 October Bundibugyo Ebola bulletin and 24 October surveillance figures explained, with DRC, Kenya and Nigeria counts, vaccine-trial status and hospital IPC precautions.
WHO launched a traditional medicine working-paper series on 23 October 2026. Its first cupping paper maps training and accreditation, not proof of clinical effectiveness.
At a Glance Editorial context: Verify the original source, publication date, scope and subsequent official updates before changing clinical or administrative practice. A draft or announcement is not necessarily a final rule. On 12 October 2026, the World Health Organization announced a five-year strategy for its Hub for Pandemic and Epidemic Intelligence in Berlin. The …
ICMR’s proposed Keylong high-altitude medicine research centre will study mountain health, climate-sensitive diseases and remote healthcare systems. Official announcement dated 11 October 2026.
FDA has approved tucatinib with trastuzumab and pertuzumab for maintenance treatment of adults with unresectable locally advanced or metastatic HER2-positive breast cancer after induction therapy.
